Ibuprofen Dr. Max Pharma

Ibuprofen, the active ingredient in Ibuprofen Dr. Max Pharma, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It treats pain, fever, inflammation and arthritis in adults and children when prescribed by a healthcare professional.

GNH USA supplies Ibuprofen Dr. Max Pharma as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts on inflammatory pathways to relieve a range of common conditions.

Pain: reduces mild to moderate pain such as headache, dental or musculoskeletal discomfort. Fever: lowers elevated body temperature associated with infection or inflammation. Inflammation: diminishes swelling in conditions like sprains or soft‑tissue injuries. Arthritis: alleviates joint pain and stiffness in osteoarthritis and rheumatoid arthritis.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal discomfort, including nausea or dyspepsia. - Headache or dizziness. - Mild skin rash or itching. - Elevated blood pressure in some patients.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Acute renal impairment or failure. - Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. - Hepatotoxicity with elevated liver enzymes. - Cardiovascular events including myocardial infarction or stroke.

Before initiating therapy, consider the following safety measures.

Assess gastrointestinal risk: evaluate history of ulcers or bleeding. Evaluate renal function: monitor creatinine in patients with kidney disease. Monitor cardiovascular status: use lowest effective dose in patients with heart disease. Use lowest effective dose: limit duration to the shortest period needed. Avoid in known hypersensitivity: discontinue if allergic reactions occur. Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Ibuprofen can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs: additive gastrointestinal toxicity. - Systemic corticosteroids: heightened ulcer risk.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in renal clearance. - Methotrexate: increased serum levels and toxicity. - Selective serotonin reuptake inhibitors (SSRIs): enhanced bleeding tendency.